These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 19249397)

  • 1. Biological therapies for inflammatory bowel diseases.
    Rutgeerts P; Vermeire S; Van Assche G
    Gastroenterology; 2009 Apr; 136(4):1182-97. PubMed ID: 19249397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment of ulcerative colitis and Crohn's disease with monoclonal antibody].
    Asakura H
    Nihon Rinsho; 2002 Mar; 60(3):531-8. PubMed ID: 11904969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biological therapies for ulcerative colitis.
    Sands BE
    Acta Gastroenterol Belg; 2001; 64(2):205-9. PubMed ID: 11475137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Biological therapies for treatment of chronic inflammatory bowel diseases. Status update].
    Metzler J; Stange EF
    Med Klin (Munich); 2002 May; 97(5):290-7. PubMed ID: 12078390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biologic therapies for chronic inflammatory bowel disease.
    Martínez-Montiel MP; Muñoz-Yagüe MT
    Rev Esp Enferm Dig; 2006 Apr; 98(4):265-91. PubMed ID: 16792456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Current concepts about the treatment of inflammatory bowel disease, biological therapy].
    Bosques-Padilla FJ; Galindo-Marines SL; Yamamoto-Farusho JK
    Rev Gastroenterol Mex; 2008; 73(4):217-30. PubMed ID: 19666271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Positioning biologic therapy for Crohn's disease and ulcerative colitis.
    Velayos FS; Sandborn WJ
    Curr Gastroenterol Rep; 2007 Dec; 9(6):521-7. PubMed ID: 18377806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New and emerging biologics in the treatment of inflammatory bowel disease: quo vadis?
    Danese S; Angelucci E
    Gastroenterol Clin Biol; 2009 Jun; 33 Suppl 3():S217-27. PubMed ID: 20117345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biologic therapy of inflammatory bowel disease.
    Sandborn WJ; Targan SR
    Gastroenterology; 2002 May; 122(6):1592-608. PubMed ID: 12016425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emerging biological treatments in inflammatory bowel diseases.
    Van Assche G; Vermeire S; Rutgeerts P
    Dig Dis; 2006; 24(1-2):131-6. PubMed ID: 16699271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How future tumor necrosis factor antagonists and other compounds will meet the remaining challenges in Crohn's disease.
    Sandborn WJ
    Rev Gastroenterol Disord; 2004; 4 Suppl 3():S25-33. PubMed ID: 15583528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The role of adhesion molecules for assessing the effectiveness of biological treatment of patients with inflammatory bowel disease].
    Boldyreva ON
    Eksp Klin Gastroenterol; 2012; (5):119-25. PubMed ID: 23402183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-TNF therapy in inflammatory bowel diseases: a huge review.
    Peyrin-Biroulet L
    Minerva Gastroenterol Dietol; 2010 Jun; 56(2):233-43. PubMed ID: 20485259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of inflammatory bowel disease].
    Schölmerich J
    Praxis (Bern 1994); 2007 Feb; 96(9):337-43. PubMed ID: 17361635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Introduction and overview: recent advances in the immunotherapy of inflammatory bowel disease.
    Hibi T; Inoue N; Ogata H; Naganuma M
    J Gastroenterol; 2003 Mar; 38 Suppl 15():36-42. PubMed ID: 12698869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Italian Society of Gastroenterology (SIGE) and the Italian Group for the study of Inflammatory Bowel Disease (IG-IBD) Clinical Practice Guidelines: The use of tumor necrosis factor-alpha antagonist therapy in inflammatory bowel disease.
    Orlando A; Armuzzi A; Papi C; Annese V; Ardizzone S; Biancone L; Bortoli A; Castiglione F; D'Incà R; Gionchetti P; Kohn A; Poggioli G; Rizzello F; Vecchi M; Cottone M; ;
    Dig Liver Dis; 2011 Jan; 43(1):1-20. PubMed ID: 20843756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New therapies for inflammatory bowel disease: from the bench to the bedside.
    Danese S
    Gut; 2012 Jun; 61(6):918-32. PubMed ID: 22115827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monoclonal antibody therapy of inflammatory bowel disease.
    van Deventer SJ; Camoglio L
    Aliment Pharmacol Ther; 1996; 10 Suppl 2():107-11; discussion 112. PubMed ID: 8899109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New biologic therapeutics for ulcerative colitis and Crohn's disease.
    Mozaffari S; Nikfar S; Abdolghaffari AH; Abdollahi M
    Expert Opin Biol Ther; 2014 May; 14(5):583-600. PubMed ID: 24502344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cell adhesion molecules in evaluation of Crohn's disease therapy].
    Lazebnik LB; Boldyreva ON; Parfenov AI; Trubitsyna IE; Shcherbakov PL; Khomeriki SG; Kniazev OV; Sagynbaeva VÉ
    Eksp Klin Gastroenterol; 2013; (3):31-8. PubMed ID: 24294769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.